UHS — Universal Health Services, Inc. stock price, charts and financials

QT68Universal Health Services, Inc.

Universal Health Services, Inc. (NYSE: UHS) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
176.69
-4.06-2.25%
UHSQT68Universal Health Services, Inc.·NYSE
176.69-2.25%
News
Down 2.2% — Leerink Partners Maintains Outperform on Universal Health Services, Raises Price Target to $205 (Benzinga).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E7.17EPS (ttm)24.66Insider Own8.86%Shs Outstand60.54MPerf Week1.06%
Market Cap10.70BForward P/E7.38EPS next Y23.96Insider Trans0.00%Shs Float50.39MPerf Month2.53%
Enterprise Value15.82BPEG0.26EPS next Q5.23Inst Own-Short Float5.11%Perf Quarter25.16%
Income1.55BP/S0.59EPS this Y-7.59%Inst Trans-Short Ratio2.86Perf Half Y-5.62%
Sales18.11BP/B1.40EPS next Y6.34%ROA9.58%Short Interest2.58MPerf YTD-18.96%
Book/sh-P/C5.85EPS next 5Y4.42%ROE20.66%52W High246.33 -28.27%Perf Year-5.71%
Cash/sh-P/FCF12.94EPS past 3/5Y36.21% 16.02%ROIC11.68%52W Low140.07 26.14%Perf 3Y39.79%
Dividend Est.0.80 (0.45%)EV/EBITDA5.61Sales past 3/5Y9.03% 8.48%Gross Margin90.69%Volatility3.66% 2.97%Perf 5Y19.85%
Dividend TTM0.80 (0.45%)EV/Sales0.87EPS Y/Y TTM44.95%Oper. Margin11.36%ATR (14)5.53Perf 10Y45.36%
Dividend Ex-DateSep 01, 2026Quick Ratio1.04Sales Y/Y TTM14.44%Profit Margin8.42%RSI (14)56.15Recom2.67
Dividend Gr. 3/5Y0.00% 31.95%Current Ratio1.12EPS Q/Q11.78%SMA201.44%Beta1.01Target Price193.00
Payout3.25%Debt/Eq0.70Sales Q/Q8.26%SMA505.59%Rel Volume2.13Prev Close180.75
Employees101,500LT Debt/Eq0.63EarningsOct 26SMA200-3.63%Avg Volume835.34KPrice176.69
IPO DateJul 09, 1981Option/ShortYes / YesEPS/Sales Surpr.0.67% 1.29%Net Debt/EBITDA1.82Volume1,777,148Change-2.25%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-03-26ReiteratedRBC CapitalSector Perform$190$183
Jul-30-26ReiteratedGoldman SachsNeutral$219$190
Jul-29-26ReiteratedUBSBuy$310$290
Jul-29-26ReiteratedRobert W. Baird$204$166
Jul-29-26ReiteratedMorgan StanleyEqual Weight$233$191
Jul-29-26ReiteratedGuggenheimBuy$195$189
Jul-28-26ReiteratedBarclaysEqual Weight$179$168
Jul-20-26ReiteratedGuggenheimBuy$211$195
Jul-13-26ReiteratedWells FargoEqual Weight$165$166
Jul-08-26DowngradeBarclaysOverweightEqual Weight$238$179
Latest News· Times ET
Sep-18-26
Sep-17-26
Sep-15-26
Sep-14-26
Sep-08-26
Aug-28-26
Aug-27-26
Aug-26-26
Aug-25-26
Aug-20-26
Aug-18-26
Aug-17-26
Company

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue18,11417,36515,828
Cost of Goods Sold Incl. D&A1,6881,6591,588
Gross Profit16,42815,70614,240
Selling, General and Administrative Excl. Other8,4618,2337,665
Research and Development
000
Other Operating Expense5,9085,4794,893
Operating Income2,0591,9941,682
Interest Expense155157188
Unusual Expense
Non-Operating Income (Expense)1241354
Net Income Before Taxes2,0261,9721,498
Income Taxes477461335
Consolidated Net Income1,5261,4891,142
Net Income From Continuing Operations1,5511,5111,163
Net Income1,5261,4891,142
EPS (Recurring)24.6623.4217.16
EPS (Basic, Before Extraordinaries)24.6623.4217.16
EPS (Diluted)24.3823.1016.82
EBITDA2,8202,7432,265
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio7.259.4410.67
Price To Sales Ratio0.590.800.76
Gross Margin90.6990.4589.97
Operating Margin11.3711.4810.63
Net Margin8.428.577.22
Shares Outstanding606467
Market Capitalization10,60113,95312,021
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$259.63$226.15$192.68$159.20$125.72 Close Price0.00K213.09K426.17K639.26K852.34KUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SUSSMAN ELLIOT J MD MBADirectorMar 13 '26Option Exercise138.801,250173,5007,363Mar 13
SUSSMAN ELLIOT J MD MBADirectorMar 13 '26Sale193.3735668,8416,113Mar 13
Singer Maria RudermanDirectorMar 12 '26Option Exercise138.802,500347,00010,384Mar 13
Miller Marc DPresident and CEOMar 12 '26Option Exercise145.77100,42514,638,889411,721Mar 13
FILTON STEVEExecutive Vice President & CFOMar 12 '26Option Exercise146.1483,23712,164,529201,738Mar 13
SUSSMAN ELLIOT J MD MBADirectorMar 11 '26Option Exercise138.801,250173,5001,250Mar 13
SUSSMAN ELLIOT J MD MBADirectorMar 11 '26Sale186.3531859,2586,113Mar 13
MILLER ALAN BExecutive ChairmanMar 10 '26Option Exercise146.14132,71219,394,9681,878,743Mar 11
Nimetz Warren J.DirectorNov 11 '25Sale223.303,817852,3448,481Nov 12
Nimetz Warren J.DirectorNov 11 '25Option Exercise138.8010,0001,388,00018,481Nov 12
MILLER ALAN BExecutive ChairmanOct 29 '25Option Exercise146.14132,71319,395,1211,851,550Oct 30
SUSSMAN ELLIOT J MD MBADirectorOct 29 '25Sale225.70965217,7996,113Oct 30
Peterson Matthew JayExecutive Vice President, UHSOct 29 '25Option Exercise146.1417,8902,614,50634,270Oct 30
SUSSMAN ELLIOT J MD MBADirectorOct 29 '25Option Exercise138.802,500347,0008,613Oct 30
Miller Marc DPresident and CEOOct 29 '25Option Exercise146.37165,00024,151,200443,054Oct 30
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.